Demonstrates improved staging and treatment planning in prostate cancer, suggesting enhanced accuracy with PSMA PET/CT.
PSMA PET/CT meaningfully changes staging, TVs, and dosimetry. It highlights the modality's value in improving accuracy in definitive RT planning.
No takes yet. Share an insight, caveat, or question.
Elsaka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: